In this episode, Scott Becker covers seven top business stories, including NVIDIA’s race with Microsoft for top market cap, Salesforce’s strong AI-driven growth, tariff setbacks affecting U.S. trade policy, and more.

In this episode, Scott Becker talks with McGuireWoods partner David Pivnick about a major constitutional challenge to the False Claims Act, the potential impact on whistleblower lawsuits, and what it could mean for healthcare litigation and government recoveries.

In this episode, Scott Becker discusses Tempus AI’s rapid growth, recent market moves, and its impact on oncology care.

In this episode, Scott Becker dives into two major topics: the surprising global shift in response to Trump’s tariff policies, and Tesla’s remarkable rebound despite sharp declines in international sales.

In this episode, Scott Becker breaks down four key business stories: Tempus AI’s stock drop, major leadership changes at Jeep, Tesla’s recovery under Elon Musk’s renewed focus, and how U.S. trade power is influencing global tariff negotiations.

In this episode, Dina DeMarco, President of Hueman Private Equity Talent Solutions, joins Scott Becker to share how her team bridges the recruitment gap for PE-backed portfolio companies—scaling hiring from staff to VP level with speed, flexibility, and cost-efficiency.

In this episode, Matt Wolf, Valuation Leader and Healthcare Senior Analyst at Elliott Davis, unpacks how higher interest rates, global financial uncertainty, and a shift away from traditional add-on acquisitions are reshaping private equity strategy, especially in the healthcare and lower middle markets.

In thia episode, Scott Becker explores the power of consistency and intentionality across different areas of life.

In this episode, Scott Becker reflects on the challenges and insights of parenting adult children.

In this episode, Scott Becker shares nine major stories shaping the business world, including surging markets driven by tariff delays, Apple’s tension with U.S. trade policy, NVIDIA’s China concerns, and more.